A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal Stent
Phase 4
Completed
- Conditions
- Subject With Primary Open-angle Glaucoma (POAG)
- Registration Number
- NCT01252914
- Lead Sponsor
- Glaukos Corporation
- Brief Summary
The purpose of this study is to assess the efficacy and safety of one iStent supra stent in the reduction of intraocular pressure associated with primary open-angle glaucoma.
- Detailed Description
The study assesses the efficacy and safety of one iStent supra stent in the reduction of intraocular pressure associated with primary open-angle glaucoma.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
- Diagnosed with primary open-angle glaucoma (POAG)
- Subjects on two topical hypotensive medications
Exclusion Criteria
- Traumatic, uveitic, neovascular, or angle closure glaucoma
- Fellow eye already enrolled
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Mean diurnal Intraocular Pressure reduction of greater than or equal to 20% at month 12 vs. baseline 12 months
- Secondary Outcome Measures
Name Time Method Mean diurnal Intraocular Pressure < 18 mmHg at month 12 12 months
Trial Locations
- Locations (1)
S.V. Malayan Ophthalmology Centre
🇦🇲Yerevan, Armenia
S.V. Malayan Ophthalmology Centre🇦🇲Yerevan, Armenia